San Francisco, CA, United States of America

Jeffrey P MacMahon


Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Jeffrey P. MacMahon

Introduction

Jeffrey P. MacMahon is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target specific receptors in the body. His work is particularly relevant for treating various diseases, including allergic and autoimmune conditions.

Latest Patents

One of his key patents is titled "Substituted anilines as CCR(4) antagonists." This patent describes aniline compounds that bind to the CCR(4) receptor, which are useful in treating diseases such as allergic diseases, autoimmune diseases, graft rejection, and cancer. This innovation highlights his commitment to advancing medical treatments through targeted therapies.

Career Highlights

Jeffrey P. MacMahon is currently associated with Chemocentryx, Inc., a company focused on developing innovative therapies for serious diseases. His role at the company allows him to apply his expertise in medicinal chemistry to real-world applications, contributing to the advancement of healthcare solutions.

Collaborations

Throughout his career, Jeffrey has collaborated with talented individuals such as Trevor T. Charvat and Junfa Fan. These collaborations have likely enriched his research and contributed to the successful development of his patented innovations.

Conclusion

In summary, Jeffrey P. MacMahon is a distinguished inventor whose work in developing CCR(4) antagonists has the potential to impact the treatment of various diseases significantly. His contributions to medicinal chemistry and his role at Chemocentryx, Inc. underscore his dedication to improving healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…